Application of digital-intelligence technology in the processing of Chinese materia medica.
Chinese medicine processing
application progress
digital and intelligent technologies
industrialization
standardization
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
04
2023
accepted:
10
08
2023
medline:
11
9
2023
pubmed:
11
9
2023
entrez:
11
9
2023
Statut:
epublish
Résumé
Processing of Chinese Materia Medica (PCMM) is the concentrated embodiment, which is the core of Chinese unique traditional pharmaceutical technology. The processing includes the preparation steps such as cleansing, cutting and stir-frying, to make certain impacts on the quality and efficacy of Chinese botanical drugs. The rapid development of new computer digital technologies, such as big data analysis, Internet of Things (IoT), blockchain and cloud computing artificial intelligence, has promoted the rapid development of traditional pharmaceutical manufacturing industry with digitalization and intellectualization. In this review, the application of digital intelligence technology in the PCMM was analyzed and discussed, which hopefully promoted the standardization of the process and secured the quality of botanical drugs decoction pieces. Through the intellectualization and the digitization of production, safety and effectiveness of clinical use of traditional Chinese medicine (TCM) decoction pieces were ensured. This review also provided a theoretical basis for further technical upgrading and high-quality development of TCM industry.
Identifiants
pubmed: 37693890
doi: 10.3389/fphar.2023.1208055
pii: 1208055
pmc: PMC10484343
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1208055Informations de copyright
Copyright © 2023 Zhang, Zhang, Cao, Liang, Xie, Tao, Chen, Yang and Zhong.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Pharm Biomed Anal. 2020 Sep 5;188:113387
pubmed: 32531683
Food Chem. 2015 Jun 15;177:361-8
pubmed: 25660898
J Sep Sci. 2014 Nov;37(21):3090-3
pubmed: 25113615
Trends Biotechnol. 2017 Oct;35(10):914-924
pubmed: 28838636
J Chromatogr A. 2022 Aug 16;1678:463364
pubmed: 35914409
Sensors (Basel). 2019 Jul 10;19(14):
pubmed: 31295908
Int J Pharm. 2021 Jun 1;602:120624
pubmed: 33892055
J Environ Manage. 2021 Mar 1;281:111915
pubmed: 33434761
Front Pharmacol. 2022 Aug 26;13:935336
pubmed: 36091795
Phytochem Anal. 2023 Apr;34(3):301-316
pubmed: 36697250
Eur J Pharm Sci. 2018 Jan 1;111:278-292
pubmed: 29020609
J Sep Sci. 2022 Oct;45(19):3774-3785
pubmed: 35938469
Zhongguo Zhong Yao Za Zhi. 2018 Sep;43(18):3795-3800
pubmed: 30384548
Eur Arch Otorhinolaryngol. 2020 Oct;277(10):2893-2906
pubmed: 32488381
Zhongguo Zhong Yao Za Zhi. 2016 Feb;41(3):357-361
pubmed: 28868848
Evid Based Complement Alternat Med. 2021 Dec 30;2021:1271953
pubmed: 35003289
Adv Exp Med Biol. 2020;1213:107-120
pubmed: 32030666
J Anal Methods Chem. 2020 Nov 4;2020:8847277
pubmed: 33204575
J Chromatogr A. 2022 Jul 19;1675:463172
pubmed: 35649309
ACS Appl Mater Interfaces. 2021 Jul 14;13(27):32058-32066
pubmed: 34197071
J Ethnopharmacol. 2023 Jan 30;301:115838
pubmed: 36257343
Acta Pharm Sin B. 2020 May;10(5):903-912
pubmed: 32528836
Food Chem. 2023 Mar 15;404(Pt B):134754
pubmed: 36332578
Comput Intell Neurosci. 2022 Mar 10;2022:3283165
pubmed: 35310597
J Ethnopharmacol. 2022 Mar 01;285:114820
pubmed: 34767834
Sensors (Basel). 2022 May 23;22(10):
pubmed: 35632349
Lancet. 2020 Feb 1;395(10221):350-360
pubmed: 32007170
J Chem Inf Model. 2021 Feb 22;61(2):587-602
pubmed: 33502191
J Pharm Biomed Anal. 2019 Feb 20;165:18-23
pubmed: 30500596
Chin Med. 2022 May 6;17(1):54
pubmed: 35524264
J Ethnopharmacol. 2023 May 10;307:116160
pubmed: 36773791
Sci Rep. 2022 Nov 21;12(1):20045
pubmed: 36414644
Mikrochim Acta. 2021 Dec 30;189(1):41
pubmed: 34970724
J Asian Nat Prod Res. 2020 Dec;22(12):1101-1120
pubmed: 33207951
Phytomedicine. 2020 Aug;74:153071
pubmed: 31537418
J Ethnopharmacol. 2021 Apr 6;269:113721
pubmed: 33359001
Zhongguo Zhong Yao Za Zhi. 2022 Mar;47(5):1177-1183
pubmed: 35343142
Acta Pharm Sin B. 2018 May;8(3):488-497
pubmed: 29881688
Front Pharmacol. 2022 Mar 10;13:842890
pubmed: 35359875
Front Big Data. 2018 Nov 19;1:6
pubmed: 33693322
Molecules. 2022 May 24;27(11):
pubmed: 35684307
Front Pharmacol. 2022 Jun 16;13:934710
pubmed: 35784754
J Pharm Sci. 2019 Mar;108(3):1203-1210
pubmed: 30773200
Molecules. 2020 Dec 13;25(24):
pubmed: 33322214
Methods. 2022 Aug;204:101-109
pubmed: 35597515
Evid Based Complement Alternat Med. 2015;2015:753942
pubmed: 26366185
J Agric Food Chem. 2019 May 1;67(17):5017-5025
pubmed: 30839206
Food Res Int. 2021 Jun;144:110366
pubmed: 34053559
Chin Med. 2018 Aug 25;13:43
pubmed: 30159006
Zhongguo Zhong Yao Za Zhi. 2016 Jul;41(14):2646-2651
pubmed: 28905600
Food Chem. 2022 Mar 30;373(Pt B):131453
pubmed: 34731807
Acta Pharm Sin B. 2015 Jan;5(1):38-46
pubmed: 26579423
J Pharm Biomed Anal. 2020 Feb 5;179:112979
pubmed: 31825798
Zhongguo Zhong Yao Za Zhi. 2019 Dec;44(23):5109-5113
pubmed: 32237345